New attack on deadly skin cancer: Double-Duty treatment before surgery
NCT ID NCT03921008
Summary
This study is testing a two-step treatment for a rare and aggressive skin cancer called angiosarcoma. First, patients receive a chemotherapy drug (paclitaxel) for several weeks, then they continue that drug while also receiving radiation therapy. The goal is to shrink the tumor and control the disease before patients undergo surgery to remove it, aiming to improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS ANGIOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.